Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.

Xia H, Zhang W, Zhang Y, Shang X, Liu Y, Wang X.

Open source

DOI
10.3389/fonc.2022.978069
Published
2022-10-18
Container
Front Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2022.978069,
  title = {Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.},
  author = {Xia H and  Zhang W and  Zhang Y and  Shang X and  Liu Y and  Wang X.},
  year = {2022},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2022.978069},
  url = {https://doi.org/10.3389/fonc.2022.978069}
}

RIS

TY  - JOUR
TI  - Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.
AU  - Xia H
AU  -  Zhang W
AU  -  Zhang Y
AU  -  Shang X
AU  -  Liu Y
AU  -  Wang X.
PY  - 2022
JO  - Front Oncol
DO  - 10.3389/fonc.2022.978069
UR  - https://doi.org/10.3389/fonc.2022.978069
ER  - 

APA

H, X., W, Z., Y, Z., X, S., Y, L., & X., W. (2022). Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.. Front Oncol. https://doi.org/10.3389/fonc.2022.978069

Source records